Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.95 | 17.75 |
| PEG Ratio (TTM) | 17.31 | 4.72 |
| P/S Ratio (TTM) | 8.82 | 3.12 |
| P/B Ratio (TTM) | 2.02 | -5.51 |
| P/FCF Ratio (TTM) | 24.67 | 29.32 |
| Price to 5YR AVG Earnings Ratio | N/A | 31.93 |
| Price to 5YR AVG FCF Ratio | N/A | 17.46 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.51% | 1,106.75% |
| ROE (TTM) | 9.77% | -403.16% |
| Net Profit Margin (TTM) | 42.10% | 18.52% |
| ROIC 5YR AVG | N/A | 9.25% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.00% | 13.24% | N/A |
| Revenue | 2.19% | 21.64% | N/A |
| Net Income | 3.03% | 13.22% | N/A |
| Cash Flow | 10.50% | 19.18% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.84 | 0.88 |
| Quick Ratio (TTM) | 0.84 | 0.71 |
| D/E Ratio (TTM) | 0.75 | -3.12 |
| Interest Coverage (TTM) | 3.19 | 3.72 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.55 | 1.42 |
| LTL to 5YR AVG FCF | N/A | 5.06 |
| Shares Outstanding Growth 5YR AVG | N/A | 6.47% |